(Sept. 20) Pfizer Inc. and partner BioNTech SE said their Covid-19 vaccine was safe and produced strong antibody responses in children ages 5 to 11 in a large-scale trial, findings that could pave the way to begin vaccinating grade-school kids within months. The long-awaited results offer one of the first looks at how well a Covid vaccine could work for younger children.
Pressure to immunize kids has been on the climb in the U.S., where a new school year has started just as the delta variant is fueling a surge in cases. In a trial with 2,268 participants, two shots of a 10 microgram dose — one-third the adult shot — produced antibody levels comparable to those seen in a trial of 16-to-25-year-olds who got the adult dose, the companies said, with similar side effects. Nick Note: The rate of infection and hospitalizations among the kiddies are soaring. The story they are not telling you…
HARD TO LOOK AT
Kids are getting infected and hospitalized and dieing. School should be out until vaccinations. Best case that is not going to happen until year end. I am working on my fun cool mask for kiddies. I will soon have product for you. The idea was to make a fun cool mask the kiddies would wear. We started with a 5 layer replaceable N95 certified filter. I got with my premed student Nichole and gave her this product. She made a bunch of the cool N95 fun masks and took them to the local playground and the kiddies went wild….
